Cargando…
6. Dose Adjustments Based on Pharmacogenetics of CYP450 Enzymes
Autor principal: | van Schaik, Ron H.N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Communications and Publications Division (CPD) of the IFCC
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975340/ https://www.ncbi.nlm.nih.gov/pubmed/27683289 |
Ejemplares similares
-
Clinical Application of Pharmacogenetics: Where are We Now?
por: van Schaik, Ron HN
Publicado: (2014) -
Drugs impact on CYP-450 enzyme family: A pharmacogenetical study of response variation
por: Kalra, Kapil, et al.
Publicado: (2009) -
Differences in CYP3A genotypes of a liver transplant recipient and the donor liver graft and adjustment of tacrolimus dose
por: Berger, Florine A., et al.
Publicado: (2019) -
No Effect of Dose Adjustment to the CYP2D6 Genotype in Patients With Severe Mental Illness
por: Koopmans, Anne B., et al.
Publicado: (2018) -
Copy number variation profiling in pharmacogenetics CYP-450 and GST genes in Colombian population
por: Ramírez, Brian, et al.
Publicado: (2019)